Back to results
US 2024/0390706 A1Published application
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
AssigneesThe U.S.A., as represented by the Secretary, Department of Health and Human Services, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
InventorsMasaru Kanekiyo, Michael Gordon Joyce, Wei Bu, Jeffrey I. Cohen, Yaroslav Tsybovsky
Life of this patent
Estimating the term…
Abstract
Anti-EBV gH antibodies, anti-EBV gL antibodies, anti-EBV gH/gL antibodies, and compositions of matter useful for the detection, diagnosis, prevention, and treatment of Epstein Barr Virus infection in humans, and methods of using those compositions of matter for the same.
Claims16
An isolated nucleic acid having a nucleotide sequence that encodes a monoclonal antibody comprising:
- a) heavy chain (h) complementary determining region (CDR) 1, CDR2 and CDR3 sequences from a sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 11, SEQ ID NO:
- 21, SEQ ID NO:
- 31, SEQ ID NO:
- 41, SEQ ID NO:
- 51, SEQ ID NO:
- 61, SEQ ID NO:
- 71, SEQ ID NO:
- 81, SEQ ID NO:
- 91, SEQ ID NO:
- 101, SEQ ID NO:
- 111, SEQ ID NO:
- 121, SEQ ID NO:
- 131, SEQ ID NO:
- 141, SEQ ID NO:
- 151, SEQ ID NO:
- 161, SEQ ID NO:
- 171, SEQ ID NO:
- 181, and SEQ ID NO:
- 191;
- and,
- b) light chain (1) CDR1, CDR2 and CDR3 sequences from a sequence selected from the group consisting of SEQ ID NO:
- 6, SEQ ID NO:
- 16, SEQ ID NO:
- 26, SEQ ID NO:
- 36, SEQ ID NO:
- 46, SEQ ID NO:
- 56, SEQ ID NO:
- 66, SEQ ID NO:
- 76, SEQ ID NO:
- 86, SEQ ID NO:
- 96, SEQ ID NO:
- 106, SEQ ID NO:
- 116, SEQ ID NO:
- 126, SEQ ID NO:
- 136, SEQ ID NO:
- 146, SEQ ID NO:
- 156, SEQ ID NO:
- 166, SEQ ID NO:
- 176, SEQ ID NO:
- 186, and SEQ ID NO:
- 196;
- wherein the monoclonal antibody binds an Epstein Barr Virus (EBV) gH protein (gH), an EBV gL protein (gL), or a gH/gL protein complex.
41 more elements
Dependencies are inferred from the claim text.